Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Human Genome Sciences Inc > Profile

Human Genome Sciences Inc (HGSI)

Market is closed

Sector: In Vitro & In Vivo Diagnostic Substances

Hedge Fund Holdings

Filing Period:

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Jabre Capital Partners Philippe Jabre	0	$0		0%
2.	AQR Capital Management Cliff Asness	0	$0		0%
3.	Millennium Management Israel Englander	0	$0		0%
4.	York Capital Management James Dinan	0	$0		0%
5.	Canyon Capital AdvisorsNOTE 3.000%11/1 Joshua Friedman And Mitchell Julis	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Watkins Officer, Director	$6.32	3,364	$21,260.48	177,469	2012-06-29	Filing
Watkins Officer, Director	$20.62	1,030	$21,238.60	169,105	2011-06-30	Filing
Glaxosmithkline Large Shareholder, Director	$14.25	59,232,487	$844,062,939.75	233,716,708	2012-08-02	Filing
Glaxosmithkline Large Shareholder, Director	$14.25	3,413,699	$48,645,210.75	174,484,221	2012-08-02	Filing
Glaxosmithkline Large Shareholder, Director	$14.25	5,686,715	$81,035,688.75	171,070,522	2012-08-01	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Simpson Officer	$27.11	22,904	$620,959.51	45,790	2011-06-01	Filing
Davis Officer	$30.00	8,653	$259,590.00	88,739	2011-05-02	Filing
Labinger Officer	$30.00	7,347	$220,410.00	0	2011-05-02	Filing
Simpson Officer	$28.99	28,015	$812,028.78	45,790	2011-04-29	Filing
Labinger Officer	$30.00	28,113	$843,390.00	0	2011-04-28	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Ifp Advisors, Inc	0	$0	0%